Inventor · disambiguated record
Alon Chen
Also filed as: CHEN ALON · CHEN ALON M
12 granted patents·8 pending applications·32 citations·filing 2006–2023
89Inventor score
Top patents by PatentIndex Score
20 records- 0190US12016876B2Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditionsYEDA RES & DEV·Filed 2022·Granted Jun 25, 2024·1 cites·10 claims
- 0287US11680263B2Micro-RNAS and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditionsYEDA RES & DEV·Filed 2021·Granted Jun 20, 2023·1 cites·9 claims
- 0386US10975373B2Micro-RNAS and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditionsYEDA RES & DEV·Filed 2018·Granted Apr 13, 2021·2 cites·6 claims
- 0483US10125365B2Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditionsYEDA RES & DEV·Filed 2015·Granted Nov 13, 2018·4 cites·11 claims
- 0583US9150858B2Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditionsCHEN ALON·Filed 2012·Granted Oct 6, 2015·8 cites·16 claims
- 0682US7507794B2Isolated soluble corticotropin releasing factor receptor type 2 (sCRFR2)RES DEV FOUNDATION·Filed 2006·Granted Mar 24, 2009·4 cites·22 claims
- 0778US8734759B2Methods of diagnosing and treating motor neuron diseasesHORNSTEIN ERAN·Filed 2009·Granted May 27, 2014·5 cites·5 claims
- 0877US7815905B2Methods of increasing insulin sensitivity or decreasing insulin secretion by administering corticotropin releasing factor receptor-2 inhibitorsRES DEV FOUNDATION·Filed 2007·Granted Oct 19, 2010·3 cites·16 claims
- 0976US10238681B2Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditionsYEDA RES & DEV·Filed 2018·Granted Mar 26, 2019·1 cites·9 claims
- 1072US8258279B2Isolated nucleic acids encoding soluble corticotropin releasing factor receptor type 2 (sCRFR2) polypeptidesCHEN ALON·Filed 2008·Granted Sep 4, 2012·1 cites·12 claims
- 1171US9901593B2Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone-associated medical conditionsYEDA RES & DEV·Filed 2015·Granted Feb 27, 2018·1 cites·7 claims
- 1268US9359607B2Methods of diagnosing and treating motor neuron diseasesYEDA RES & DEV·Filed 2014·Granted Jun 7, 2016·1 cites·8 claims
- 1367US2021369761A1Methods of treating motor neuron diseasesYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 1467US2024026357A1Modified mir-135, conjugated form thereof, and uses of sameYEDA RES & DEV·Filed 2023·Application pending·0 cites
- 1561US2020246372A1Methods of treating motor neuron diseasesYEDA RES & DEV·Filed 2020·Application pending·0 cites
- 1661US2019167712A1Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditionsYEDA RES & DEV·Filed 2019·Application pending·0 cites
- 1757US2018064748A1Methods of treating motor neuron diseasesYEDA RES & DEV·Filed 2016·Application pending·0 cites
- 1856US2024065988A1Combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disordersYEDA RES & DEV·Filed 2023·Application pending·0 cites
- 1948US2011288159A1Methods of expressing a polypeptide in the brain and nucleic acid constructs capable of sameCHEN ALON·Filed 2009·Application pending·0 cites
- 2034US2015197810A1DOWNREGULATION OF miR-218 MAY BE USED AS A BIOMARKER FOR HUMAN ALSYEDA RES & DEV·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →